Published in

Nature Research, Nature Medicine, 1(29), p. 236-246, 2022

DOI: 10.1038/s41591-022-02107-4

Links

Tools

Export citation

Search in Google Scholar

Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae

Journal article published in 2022 by Nina Zaks, Renyuan Zha, Ryan Conrad Thompson, Nicole W. Simons, Lillian Wilkins, Ying-Chih Wang, Esther Cheng, Carlo Cervia ORCID, Diane Marie Del Valle, Gabriel E. Hoffman, Brian Fennessy, Konstantinos Mouskas, Jessica Le Berichel, Nancy J. Francoeur, Jessica Le Berichel and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractPost-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are debilitating, clinically heterogeneous and of unknown molecular etiology. A transcriptome-wide investigation was performed in 165 acutely infected hospitalized individuals who were followed clinically into the post-acute period. Distinct gene expression signatures of post-acute sequelae were already present in whole blood during acute infection, with innate and adaptive immune cells implicated in different symptoms. Two clusters of sequelae exhibited divergent plasma-cell-associated gene expression patterns. In one cluster, sequelae associated with higher expression of immunoglobulin-related genes in an anti-spike antibody titer-dependent manner. In the other, sequelae associated independently of these titers with lower expression of immunoglobulin-related genes, indicating lower non-specific antibody production in individuals with these sequelae. This relationship between lower total immunoglobulins and sequelae was validated in an external cohort. Altogether, multiple etiologies of post-acute sequelae were already detectable during SARS-CoV-2 infection, directly linking these sequelae with the acute host response to the virus and providing early insights into their development.